CA1271298A - Polypeptides with an anticoagulant action, a process to prepare or obtain them, their use and agents containing them - Google Patents

Polypeptides with an anticoagulant action, a process to prepare or obtain them, their use and agents containing them

Info

Publication number
CA1271298A
CA1271298A CA000479344A CA479344A CA1271298A CA 1271298 A CA1271298 A CA 1271298A CA 000479344 A CA000479344 A CA 000479344A CA 479344 A CA479344 A CA 479344A CA 1271298 A CA1271298 A CA 1271298A
Authority
CA
Canada
Prior art keywords
polypeptide
formula
thr
group
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000479344A
Other languages
English (en)
French (fr)
Inventor
Dominique Tripier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of CA1271298A publication Critical patent/CA1271298A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA000479344A 1984-04-18 1985-04-17 Polypeptides with an anticoagulant action, a process to prepare or obtain them, their use and agents containing them Expired - Lifetime CA1271298A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DEP3414593.1 1984-04-18
DE3414593 1984-04-18
DEP3438296.8 1984-10-19
DE19843438296 DE3438296A1 (de) 1984-04-18 1984-10-19 Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel

Publications (1)

Publication Number Publication Date
CA1271298A true CA1271298A (en) 1990-07-03

Family

ID=25820510

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000479344A Expired - Lifetime CA1271298A (en) 1984-04-18 1985-04-17 Polypeptides with an anticoagulant action, a process to prepare or obtain them, their use and agents containing them

Country Status (18)

Country Link
US (1) US4668662A (h)
EP (1) EP0158986B1 (h)
JP (1) JP2552263B2 (h)
KR (1) KR930000054B1 (h)
AR (1) AR242800A1 (h)
AU (1) AU580295B2 (h)
CA (1) CA1271298A (h)
DE (2) DE3438296A1 (h)
DK (1) DK171824B1 (h)
ES (3) ES8605772A1 (h)
FI (1) FI851521A7 (h)
GR (1) GR850942B (h)
HU (1) HU198085B (h)
IE (1) IE60581B1 (h)
IL (1) IL74948A (h)
NO (1) NO851535L (h)
PT (1) PT80301B (h)
ZA (1) ZA852854B (h)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
DE3583361D1 (de) * 1984-06-14 1991-08-08 Ucp Gen Pharma Ag Verfahren zur herstellung von thrombin-inhibitoren.
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
FI96956C (fi) * 1985-04-11 1996-09-25 Hoechst Ag Menetelmä terapeuttisesti käyttökelpoisen hirudiinijohdannaisen valmistamiseksi
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
US6005071A (en) * 1987-01-23 1999-12-21 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US5789540A (en) * 1987-01-23 1998-08-04 Merrell Pharmaceuticals Inc. Anticoagulant peptides
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem
US5236898A (en) * 1987-05-21 1993-08-17 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5192745A (en) * 1987-05-21 1993-03-09 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
NZ228995A (en) * 1988-05-10 1992-03-26 Merrell Dow Pharma Hirudin peptide derivatives and pharmaceutical compositions
US4971953A (en) * 1988-05-10 1990-11-20 Merrell Dow Pharmaceuticals Anticoagulant peptide alcohols
FI905825A0 (fi) * 1988-05-27 1990-11-26 Magainin Sciences Inc Amfifiliska peptider och deras anvaendning.
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
DE3819078A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Amblyommin, ein neuer wirkstoff fuer die antikoagulationstherapie
DE58907266T2 (de) * 1988-06-11 1994-09-29 Ciba Geigy Ag Polypeptide mit einer die Koagulierung hemmenden Wirkung.
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
US4861865A (en) * 1989-01-23 1989-08-29 Washington University Novel antithrombin peptide
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
DE3939801A1 (de) * 1989-12-01 1991-06-06 Basf Ag Neue proteine und ihre herstellung
JPH07504152A (ja) * 1990-02-08 1995-05-11 マゲイニン　ファーマスーティカルズ，　インコーポレーテッド 生物活性ペプチドおよび標的細胞、ウイルス、あるいはウイルス感染細胞の成長を抑制する方法
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
AU641215B2 (en) * 1990-02-13 1993-09-16 Merrell Dow Pharmaceuticals Inc. Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
WO1991017760A1 (en) * 1990-05-14 1991-11-28 Magainin Sciences Inc. Composition of and treatment with biologically active peptides having d-amino acid residues
JPH05507718A (ja) * 1990-06-27 1993-11-04 マゲイニン　サイエンセズ　インコーポレーテッド 生物活性ペプチドおよびｄｎａギラーゼを阻害する抗生物質よりなる組成物と治療法
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
AU648096B2 (en) * 1990-07-24 1994-04-14 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
US6514730B1 (en) * 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
JPH07500342A (ja) * 1991-10-16 1995-01-12 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア 生物学的活性ペプチドおよび抗生物質を有する組成物およびこれを用いた治療
DE4140381A1 (de) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet
HUT73187A (en) * 1993-06-11 1996-06-28 Merrell Pharma Inc Trifunctional antithrombin and antiplatelet peptides
NZ270194A (en) * 1994-01-07 1996-05-28 Ciba Geigy Ag Hirustasin, a serine protease inhibitor from hirudo medicinalis
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19529997C1 (de) 1995-08-16 1997-04-10 Hoechst Ag Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
DE19543737A1 (de) 1995-11-24 1997-05-28 Hoechst Ag Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices
DE19544233A1 (de) 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
EP0787569B1 (en) 1996-01-31 2002-10-02 Sumitomo Bakelite Company Limited Method of producing epoxy resin-encapsulated semiconductor device
DE19607239A1 (de) 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
CN101095697A (zh) * 2006-06-28 2008-01-02 李振国 水蛭和/或地龙分子量5800道尔顿以下的提取物
US9056118B2 (en) * 2007-06-26 2015-06-16 Mudanjiang Youbo Pharmaceutical Co., Ltd. Extract for preventing of treating thrombotic diseases
KR20110089427A (ko) * 2008-11-19 2011-08-08 아반토르 퍼포먼스 머티리얼스, 인크. 페녹시 알킬 및 알콕시- 또는 페녹시-페닐 알킬 리간드에 기반한 새로운 크로마토그래피 매질

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
CA1341417C (fr) * 1984-03-27 2003-01-21 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens

Also Published As

Publication number Publication date
FI851521A0 (fi) 1985-04-16
US4668662A (en) 1987-05-26
IE60581B1 (en) 1994-07-27
DE3438296A1 (de) 1985-11-07
EP0158986B1 (de) 1993-09-15
DK173985A (da) 1985-10-19
ES8605771A1 (es) 1985-12-16
IL74948A0 (en) 1985-08-30
NO851535L (no) 1985-10-21
ES542311A0 (es) 1985-12-16
KR850007801A (ko) 1985-12-09
JP2552263B2 (ja) 1996-11-06
IL74948A (en) 1989-09-10
DK173985D0 (da) 1985-04-17
AR242800A1 (es) 1993-05-31
EP0158986A2 (de) 1985-10-23
DK171824B1 (da) 1997-06-23
AU580295B2 (en) 1989-01-12
EP0158986A3 (en) 1988-09-21
ES8605770A1 (es) 1985-12-16
ZA852854B (en) 1985-11-27
GR850942B (h) 1985-11-25
AU4136485A (en) 1985-10-24
PT80301B (de) 1987-02-10
FI851521L (fi) 1985-10-19
HUT37806A (en) 1986-02-28
FI851521A7 (fi) 1985-10-19
ES542309A0 (es) 1985-12-16
JPS60233098A (ja) 1985-11-19
PT80301A (de) 1985-05-01
DE3587576D1 (de) 1993-10-21
ES542310A0 (es) 1985-12-16
ES8605772A1 (es) 1985-12-16
KR930000054B1 (ko) 1993-01-06
HU198085B (en) 1989-07-28
IE850983L (en) 1985-10-18

Similar Documents

Publication Publication Date Title
CA1271298A (en) Polypeptides with an anticoagulant action, a process to prepare or obtain them, their use and agents containing them
US4791100A (en) Novel polypeptides with a blood coagulation-inhibiting action, processes for their preparation and isolation, their use and agents containing them
US3853837A (en) Novel nonapeptide amide analogs of luteinizing hormone releasing factor
US4636489A (en) Modified protease inhibitors, process for their preparation, and pharmaceutical compositions prepared therefrom
Schwyzer et al. The chemistry and pharmacology of angiotensin
RU2050160C1 (ru) Полипептид, полученный из ткани или секрета пиявок hirudinaria manillensis, специфически ингибирующий тромбин
US4093610A (en) Process for producing triglycyl-lysine vasopressin and intermediates therefor
CA1144160A (en) Process for the manufacture of lh-rh and lh-rh analogs using glu-his(dnp)-oh
EP0016612B1 (en) Peptides having ubiquitin-like activity, process for their preparation, therapeutic compositions containing them and their use
CA1137467A (en) Process for the preparation of somatostatin
EP0348086A2 (en) Novel peptides, their use as immuno suppressants and processes for their preparation
CA1067069A (en) Process for making an octapeptide useful for the treatment of diabetes
Čechová et al. [59] Bull seminal plasma proteinase inhibitors
PL111979B1 (en) Process for preparing novel peptides
JPH0631314B2 (ja) 新規なゴナドリベリン誘導体
Burke et al. Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analog.[21-Asparaginamide-A] insulin
US5322926A (en) Isohirudins
Diaz et al. A large-scale synthesis of somatostatin for clinical use by a novel alternating solution/solid-phase procedure
Torres et al. The incorporation of sugar moieties to neuropeptides: comparative study of different methods
Fiedler PIG PANCREATIC KALLIKREIN: STRUCTURE AND CATALYTIC PROPERTIES¹
US4637997A (en) Hexapeptide, process for obtaining II and the pharmaceutical compositions containing II
SHIMOKURA et al. Studies on Peptides. CXXXVII.: Conventional Solution Synthesis of Porcine Hypothalamic Growth Hormone Releasing Factor (pGRF)
Acher Chemistry of neurohypophysial hormones
Tomatis et al. STUDIES ON TRYPSIN INHIBITORS: Part I. Synthesis of Protected Peptides Related to Sequence 1–10 of Porcine Pancreatic Secretory Trypsin Inhibitor II (Kazal)
YAJIMA et al. Studies on peptides. LXVIII. Synthesis of the tritriacontapeptide amide corresponding to the entire amino acid sequence of the desulfated form of porcine cholecystokinin-pancreozymin (CCK-PZ)

Legal Events

Date Code Title Description
MKEX Expiry